top of page

Neuroprotective efficacy of ANAVEX 2-73, a novel tetrahydrofuran derivative targeting the sigma-1...

  • Writer: ANAVEX® Life Sciences Corp.
    ANAVEX® Life Sciences Corp.
  • Sep 11, 2010
  • 1 min read

Neuroprotective efficacy of ANAVEX 2-73, a novel tetrahydrofuran derivative targeting the sigma-1 chaperone protein, in a mouse model of Alzheimer’s disease: Analyses of administration schedules and combination studies with donepezil and memantine.


 
 
bottom of page